Conmed Corp. Appoints Executive V.P.

Conmed Corporation has gained another executive team member.

The company recently appointed Peter Shagory as executive vice president of strategy and corporate development, responsible for managing Conmed’s global business development and strategic business opportunities.

Shagory brings to Conmed more than 20 years of experience in healthcare venture investing and mergers and acquisitions through his previous venture capital, investment banking and corporate roles.

Most recently, Shagory led the strategy and business development efforts for Cardinal Health’s Medical Products Group within the Medical Segment, where he played a key role in the firm’s entry into the interventional cardiovascular and the advanced wound care categories. Prior to that, he led the healthcare and life sciences investment effort at Baird Venture Partners, focusing on medical technology and research tools and diagnostics.

“We are very pleased to welcome Pete to Conmed’s executive team. His deep understanding of business development strategies and his investment expertise will be invaluable as we continue to build on our position in the medical device industry,” said Curt R. Hartman, Conmed’s president and CEO.

hagory earned an M.B.A. from Dartmouth’s Tuck School of Business and a bachelor of science degree in Finance from Miami University in Oxford, Ohio.

“I am thrilled to join Conmed during this exciting period in the company’s history, and I look forward to being a part of shaping Conmed’s growth strategy and enhancing the company’s profile around the world,” Shagory said in prepared remarks.

Conmed is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Utica, N.Y.-based company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Conmed has a direct selling presence in 16 countries outside the United States, and international sales constitute more than 50 percent of its total sales.